FTC, States Ask Federal Court to Hold Martin Shkreli in Contempt for Allegedly Violating Lifetime Ban from Pharmaceutical Industry
Articleftc.gov
Commission cites evidence it alleges shows that Shkreli repeatedly violated a 2022 order that banned him from working in the pharmaceutical industry for life The Federal Trade Commission and seven states today asked a federal judge to hold Martin Shkreli in contempt based on their allegations that he flagrantly and repeatedly violated a 2022 court order that banned him from the pharmaceutical industry. View Press Release
Source: FTC Press ReleasesPublished: Oct 13, 2026
Last updated Oct 14, 2026 by ATDb automated enrichment